+49 170 62 47 020
Hartmut Goldschmidt

Professor

Hartmut Goldschmidt

Hematologist, Oncologist

University Hospital Heidelberg

About the doctor

Profile

Treatment of multiple myeloma and plasmacytoma, management of leukemias (AML, ALL, CLL, CML), allogeneic stem cell transplantation and bone marrow transplantation, CAR-T cell therapy and targeted molecular therapies, chemotherapy, immunomodulatory regimens, and palliative care for advanced hematologic malignancies

Work experience

39 years

Scientific activity

Author of over 1,000 peer-reviewed scientific publications — one of the most cited hematologists in Europe

Recipient of the International Myeloma Foundation Award

Honored with the Order of Merit of the Federal Republic of Germany (Bundesverdienstkreuz)

Awarded the prestigious Paul Martini Prize for outstanding research in the development of therapeutic agents

Thanks to novel treatment concepts, patient survival has significantly increased—and quality of life has markedly improved.

Hartmut Goldschmidt

Data

Director, Department of Internal Medicine V (Hematology, Oncology, and Rheumatology)

Chairman, German-Speaking Myeloma Multicenter Group (GMMG)

Ranked among Germany’s Top 100 Hematologists by FOCUS magazine

Community

Consists of 14 professional communities

Fill out an application